reformulation

Go sign green light

Pharma

Handa's Cabometyx formulation no threat to Exelixis: analysts

Still, various factors mean the nod for Handa’s Cabometyx reformulation is unlikely to pose a threat to Exelixis, analysts have said.

Fraiser Kansteiner Sep 11, 2026 2:06pm

graphic art of a right hand signing something

Biogen taps Alteogen for help developing 2 subQ biologics

Mar 25, 2026 10:55am

Green traffic light

FDA approves Shorla's oral liquid version of Novartis' Gleevec

Nov 26, 2024 11:18am

FDA

FDA rejects Outlook's Avastin reformulation for eye disease

Aug 30, 2023 11:30am

Merck KGaA

Merck KGaA under investigation in France over thyroid medication

Oct 19, 2022 11:07am

deal

Citius pays Dr. Reddy's $40M for Ontak replacement

Sep 7, 2021 3:25pm